Signal

$VRTX

- Vertex reported Q1 2026 total revenue of $2.99 billion (up 8% vs.

VRTX

$491.34

+2.32%

What changed

$VRTX - Vertex reported Q1 2026 total revenue of $2.99 billion (up 8% vs. Q1 2025) and reiterated full-year guidance, while completing its rolling BLA submission for povetacicept in IgA nephropathy following positive Phase 3 interim data.

Why it matters

- Vertex reported Q1 2026 total revenue of $2.99 billion (up 8% vs.

Sources

pipeline